The cyclin-dependent kinase inhibitor flavopiridol potentiates doxorubicin efficacy in advanced sarcomas: preclinical investigations and results of a phase I dose-escalation clinical trial (Q35931388)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The cyclin-dependent kinase inhibitor flavopiridol potentiates doxorubicin efficacy in advanced sarcomas: preclinical investigations and results of a phase I dose-escalation clinical trial |
scientific article |
Statements
1 reference
The cyclin-dependent kinase inhibitor flavopiridol potentiates doxorubicin efficacy in advanced sarcomas: preclinical investigations and results of a phase I dose-escalation clinical trial (English)
1 reference
Jason J Luke
1 reference
David R D'Adamo
1 reference
Mark A Dickson
1 reference
Mary Louise Keohan
1 reference
Richard D Carvajal
1 reference
Elgilda Musi
1 reference
Gary K Schwartz
1 reference
28 February 2012
1 reference
1 reference
2638-2647
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference